2
Clinical Trials associated with BOR-15001L7A Randomized, Open Label, Non-inferiority Study to Compare the Safety and Efficacy of BOR15001L7 to Docosanol 10% in Patients With Recurrent Herpes Labialis
BOR15001L7 is a natural product. The primary objective of this study is to demonstrate its non-inferiority to docosanol 10% based on the healing time of cold sores in patients with recurrent herpes labialis.
/ Unknown statusNot Applicable A Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety and Efficacy of a Topical Natural Health Product for the Treatment of Herpes Labialis
The aim of this study is to determine the safety and efficacy of a topical natural health product in comparison to placebo for the treatment of herpes labialis.
100 Clinical Results associated with BOR-15001L7
100 Translational Medicine associated with BOR-15001L7
100 Patents (Medical) associated with BOR-15001L7
100 Deals associated with BOR-15001L7